Table 4: Changes in the ALBI and CONUT scores at baseline, when starting and discontinuing lenvatinib, and after TAI with DEB-TACE in the second-line group.

Parameter

  Baseline

  LEN stop

After second-line

ALBI score

−2.26±0.1

−1.6±0.68

−1.88±0.34

CONUT score

2.75±2.22

  7.0±0.82＊

　5.0±0.82＊

Parameter are described as mean±SD at baseline, LEN stop and after second line. The differences in parameters were analyzed using a one-way measures ANOVA. * p=0.01.

ALBI: Albumin-Bilirubin; CONUT: Controlling Nutritional Status; LEN: Lenvatinib; DEB-TACE: Drug-Eluting Beads Transarterial Chemoembolization; TAI: Transcatheter Arterial Infusion.